Chlorzoxazone
Spezifikationen
95-25-0CAS-Nummer
202-403-9EG-Nummer
5-chloro-3H-1,3-benzoxazol-2-oneIUPAC-Name
C7H4ClNO2Chemische Formel
169.56 g/molMolekulargewicht
chlorzoxazone; 95-25-0; Paraflex; 5-Chloro-2(3H)-benzoxazolone; 5-Chloro-2-benzoxazolone; 2(3H)-Benzoxazolone, 5-chloro-; 5-Chloro-2-benzoxazolinone; 5-Chloro-2-hydroxybenzoxazole; 5-Chloro-2-benzoxazolol; Parafon Forte DSC; 5-Chlorobenzoxazolidone; 5-chloro-3H-1,3-benzoxazol-2-one; Chlorzoxane; Parafon; Strifon Forte Dsc; 2-Hydroxy-5-chlorobenzoxazole; Chlorzoxazonum; Clorzoxazona; Strifon; 5-chlorobenzoxazolin-2-one; DTXSID9022813; 5-chloro-2,3-dihydro-1,3-benzoxazol-2-one; H0DE420U8G; CHEBI:3655; DTXCID302813; NSC26189; chlorozoxazone; Clorzoxazone; Parafon-Forte; Parafon Dsc; RefChem:5678; M03BB03; 202-403-9; Chloroxazone; Chlorzoxazon; Biomioran; Myoflexine; Escoflex; Miotran; Neoflex; Solaxin; Mioran; Myoflexin; Pathorysin; 5-Chlorobenzo[d]oxazol-2(3H)-one; Usaf ma-10; 5-Chloro-1,3-benzoxazol-2(3H)-one; 5-Chlorobenzoxazol-2-one; 5-Chlorobenzoxazolone; 5-Chlorbenzoxazolin-2-on; 5-Chloro-3(H)-2-benzoxazolone; 5-Chlorobenzoksazolon-2; 5-Chlorobenzoksazolinon-2; MFCD00005717; NSC 26189; 2-BENZOXAZOLINONE, 5-CHLORO-; 5-chlorobenzo[d]oxazol-2-ol; 5-chloro-3H-benzooxazol-2-one; 5-chloro-1,3-benzoxazol-2-ol; CHEMBL1371; MLS000069380; Chlorsoxazone; Klorzoxazon; Nyoflex; Remofleks; Parafon Forte; NSC-26189; s4155; CAS-95-25-0; NCGC00015238-02; SMR000058269; CLW; Chlorzoxazonum [INN-Latin]; Clorzoxazona [INN-Spanish]; chlorzoxazona; 5-chloro-3-hydrobenzoxazol-2-one; Lorzone; 5-Chlorobenzoksazolon-2 [Polish]; 5-Chlorobenzoksazolinon-2 [Polish]; Paraflex (TN); SR-01000075207; EINECS 202-403-9; component of Parafon Forte; UNII-H0DE420U8G; AI3-63119; Chlorzoxazone (JAN/USP/INN); Prestwick_62; Chlorzoxazone [USP:INN:BAN:JAN]; 5-Chlorobenzoxazolinone; Spectrum_000148; Chlorzoxazone (Standard); Opera_ID_1659; Prestwick0_000163; Prestwick1_000163; Prestwick2_000163; Prestwick3_000163; Spectrum2_001149; Spectrum3_000350; Spectrum4_000287; Spectrum5_000745; Lopac-C-4397; CHLORZOXAZONE [MI]; C 4397; CHLORZOXAZONE [INN]; CHLORZOXAZONE [JAN]; 5-Chloro-benzooxazol-2-ol; 5-chloro-2-benzoxazolinoone; 5-chloro-benzoxazolin-2-one; Lopac0_000253; SCHEMBL35177; SCHEMBL35178; BSPBio_000025; BSPBio_002019; CHLORZOXAZONE [VANDF]; KBioGR_000814; KBioSS_000628; WLN: T56 BMVOJ HG; CHLORZOXAZONE [MART.]; DivK1c_000895; SPECTRUM1500188; SPBio_001077; SPBio_001946; CHLORZOXAZONE [USP-RS]; CHLORZOXAZONE [WHO-DD]; BPBio1_000029; GTPL2322; orb1307897; orb3025783; SCHEMBL4269294; SCHEMBL5534934; SCHEMBL29720120; HMS502M17; HY-B1462R; KBio1_000895; KBio2_000628; KBio2_003196; KBio2_005764; KBio3_001239; NINDS_000895; HMS1568B07; HMS1920O07; HMS2091E14; HMS2095B07; HMS2235I19; HMS3259I15; HMS3260D08; HMS3373P17; HMS3652K22; HMS3712B07; HMS3885N07; HMS5082A22; Pharmakon1600-01500188; CHLORZOXAZONE [ORANGE BOOK]; ALBB-012641; HY-B1462; MSK10528; STR00805; CHLORZOXAZONE [USP IMPURITY]; Tox21_110105; Tox21_500253; BDBM50290811; CCG-40323; CHLORZOXAZONE [USP MONOGRAPH]; EBC-12579; EBC-44296; NSC756693; SBB003864; STK071582; AKOS000404381; Tox21_110105_1; component of Parafon Forte (Salt/Mix); CS-5155; DB00356; FC20416; HG-0202; LP00253; NC00499; NSC-756693; SDCCGSBI-0050241.P005; 5-chloro-1,3-benzoxazole-2(3H)-one; IDI1_000895; Chlorzoxazone 1.0 mg/ml in Acetonitrile; NCGC00015238-01; NCGC00015238-03; NCGC00015238-04; NCGC00015238-05; NCGC00015238-06; NCGC00015238-07; NCGC00015238-08; NCGC00015238-09; NCGC00015238-10; NCGC00015238-13; NCGC00015238-24; NCGC00093714-01; NCGC00093714-02; NCGC00093714-03; NCGC00093714-04; NCGC00260938-01; 5-Chloro-1,3-benzoxazol-2(3H)-one #; AC-12192; BP-11613; SBI-0050241.P004; DB-057571; AB00051947; C2237; EU-0100253; NS00001077; ST45024437; SW196377-3; EN300-31026; C07931; D00771; D78096; AB00051947_05; AB00051947_06; C294458; F358326; Q3294630; SR-01000075207-1; SR-01000075207-3; SR-01000075207-5; BRD-K98174813-001-05-7; BRD-K98174813-001-08-1; BRD-K98174813-001-17-2; BRD-K98174813-001-18-0; Z57183224; Chlorzoxazone, United States Pharmacopeia (USP) Reference Standard; InChI=1/C7H4ClNO2/c8-4-1-2-6-5(3-4)9-7(10)11-6/h1-3H,(H,9,10Synonyme
Produkte, die Chlorzoxazone enthalten
Seite 1 von 4
Unternehmen, die Chlorzoxazone verkaufen
한미
한미약품(주)Republic of Korea동국
동국제약(주)Republic of Korea삼진
삼진제약(주)Republic of Korea(주
(주)에이프로젠바이오로직스Republic of Korea일양
일양약품(주)Republic of Korea(주
(주)넥스팜코리아Republic of Korea(주
(주)녹십자Republic of Korea코오
코오롱제약(주)Republic of Korea진양
진양제약(주)Republic of Korea오스
오스틴제약(주)Republic of KoreaSeite 1 von 4